Results 151 to 160 of about 64,274 (180)

Is Clinical Outcome Pathogen Related? Characteristics and Outcomes of ICU Patients with Severe Acute Respiratory Infections: Focusing on Respiratory Syncytial Virus, Human Metapneumovirus, Influenza Virus, and Parainfluenza Virus. [PDF]

J Intensive Care Med
van der Bie S, Fluit RC, Neijzen T, Euser SM, van Gorp ECM, Kalpoe J, Souverein D, Snijders D, Du Toit J, Osterhaus ADME, Gommers D, van Lelyveld SFL, Goeijenbier M.   +12 more
europepmc   +1 more source

Intranasal bovine/human parainfluenza virus 3 vaccine candidates expressing human metapneumovirus wild-type or pre-fusion F protein elicit protective immunity against human metapneumovirus in hamsters. [PDF]

J Virol
Saul S, Dahal B, Luongo C, Liu X, Yang L, Santos C, Dai J, Zhang L, Buchholz UJ, Munir S.   +9 more
europepmc   +1 more source

Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial. [PDF]

Sci Adv
Spearman P, Jin H, Xiao P, Knopp K, Radziewicz H, Tellier M, Larsen SE, Berube BJ, Song X, Kidd J, Singh K, Li Z, Gingerich MC, Wu S, John SP, Branche A, Falsey AR, Coler R, Villinger FJ, He B.   +19 more
europepmc   +1 more source

A rare case of subcutaneous emphysema in a young and healthy patient with parainfluenza virus 3 pneumonia. [PDF]

Respirol Case Rep
Akeely YY, Alesa S, Hassan HG, Almarzouqi S, Alchammat MZ, Elghor O, Patel SB, Shaat EH.   +7 more
europepmc   +1 more source

The Cap-proximal secondary structures of the 5'UTRs of parainfluenza virus 5 mRNAs specify differential sensitivity to type I interferon and IFIT1. [PDF]

J Gen Virol
Hankinson J, Young D, Wignall-Fleming EB, Lukoszek R, Cowling VH, Randall R, Goodbourn S.   +6 more
europepmc   +1 more source